CN1896738A - Fluorescent nano-particle with surface biological function, its production and use - Google Patents
Fluorescent nano-particle with surface biological function, its production and use Download PDFInfo
- Publication number
- CN1896738A CN1896738A CN 200610025985 CN200610025985A CN1896738A CN 1896738 A CN1896738 A CN 1896738A CN 200610025985 CN200610025985 CN 200610025985 CN 200610025985 A CN200610025985 A CN 200610025985A CN 1896738 A CN1896738 A CN 1896738A
- Authority
- CN
- China
- Prior art keywords
- fluorescent
- nano particles
- particles
- hud typed
- surface biological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 72
- 230000008827 biological function Effects 0.000 title 1
- 239000002245 particle Substances 0.000 claims abstract description 42
- 239000000126 substance Substances 0.000 claims abstract description 35
- 125000000524 functional group Chemical group 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 20
- 210000004027 cell Anatomy 0.000 claims description 15
- 239000000377 silicon dioxide Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 8
- 239000004530 micro-emulsion Substances 0.000 claims description 8
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 7
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 238000005576 amination reaction Methods 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- -1 amino, carboxyl Chemical group 0.000 claims description 5
- 108020004707 nucleic acids Proteins 0.000 claims description 5
- 102000039446 nucleic acids Human genes 0.000 claims description 5
- 150000007523 nucleic acids Chemical class 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 235000012239 silicon dioxide Nutrition 0.000 claims description 5
- 210000004895 subcellular structure Anatomy 0.000 claims description 5
- 229920000936 Agarose Polymers 0.000 claims description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 4
- 239000004593 Epoxy Substances 0.000 claims description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 3
- 229920000098 polyolefin Polymers 0.000 claims description 3
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims description 2
- 108010004729 Phycoerythrin Proteins 0.000 claims description 2
- 238000007306 functionalization reaction Methods 0.000 claims 12
- 230000001476 alcoholic effect Effects 0.000 claims 2
- 241001597008 Nomeidae Species 0.000 claims 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 claims 1
- 210000002845 virion Anatomy 0.000 claims 1
- 239000010410 layer Substances 0.000 abstract description 11
- 239000011258 core-shell material Substances 0.000 abstract description 10
- 238000001514 detection method Methods 0.000 abstract description 8
- 239000012792 core layer Substances 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000593 microemulsion method Methods 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 9
- 125000003277 amino group Chemical group 0.000 description 9
- 239000002086 nanomaterial Substances 0.000 description 9
- 239000008363 phosphate buffer Substances 0.000 description 9
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical group O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 8
- 239000011259 mixed solution Substances 0.000 description 8
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 125000003396 thiol group Chemical group [H]S* 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 108020004459 Small interfering RNA Proteins 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- 238000009210 therapy by ultrasound Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000001069 Raman spectroscopy Methods 0.000 description 3
- 230000021523 carboxylation Effects 0.000 description 3
- 238000006473 carboxylation reaction Methods 0.000 description 3
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 108091032955 Bacterial small RNA Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000001237 Raman spectrum Methods 0.000 description 2
- 229910018557 Si O Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 2
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 238000000077 Auger electron appearance potential spectroscopy Methods 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910021419 crystalline silicon Inorganic materials 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 125000003563 glycoside group Chemical group 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- TXDNPSYEJHXKMK-UHFFFAOYSA-N sulfanylsilane Chemical compound S[SiH3] TXDNPSYEJHXKMK-UHFFFAOYSA-N 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000001845 vibrational spectrum Methods 0.000 description 1
Images
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
本发明涉及一种表面生物功能化的核壳型荧光纳米粒子及其制备方法和应用。该粒子具备核壳型结构,内核层中包裹荧光物质;外壳层由荧光通透物质构成;并且在外壳层表面修饰有机官能团。通过反相微乳液法合该纳米粒子,继而在其表面进行化学修饰使其成为生物功能化纳米粒子。该纳米粒子在细胞生物学、超微化学、生物大分子检测和医学体内诊断等领域具有重要应用前景。
The invention relates to a surface biofunctionalized core-shell fluorescent nanoparticle, a preparation method and application thereof. The particles have a core-shell structure, the inner core layer is wrapped with fluorescent substances; the outer shell layer is composed of fluorescent transparent substances; and the surface of the outer shell layer is decorated with organic functional groups. The nanoparticles are synthesized by inverse microemulsion method, and then the surface is chemically modified to become biofunctional nanoparticles. The nanoparticle has important application prospects in the fields of cell biology, ultramicrochemistry, biomacromolecule detection, and medical in vivo diagnosis.
Description
背景技术Background technique
近年来,生物检测技术迅猛发展,其中超敏感荧光检测技术的发展为在复杂环境中进行生物分子的研究提供了条件。而超敏感荧光检测技术的建立又有赖于无毒和生物相容性发光材料的成功研制。In recent years, biological detection technology has developed rapidly, among which the development of ultra-sensitive fluorescence detection technology provides conditions for the study of biomolecules in complex environments. The establishment of ultra-sensitive fluorescence detection technology depends on the successful development of non-toxic and biocompatible luminescent materials.
有机荧光物质是经典的荧光物质,虽然有机荧光物质由于其固有的性质有其缺点,如荧光效率问题等等,但作为经典的荧光物质相对于目前的无机荧光物质仍有其广泛应用的领域,如应用于流式细胞术、应用于抗体标记等等。Organic fluorescent substances are classic fluorescent substances. Although organic fluorescent substances have their shortcomings due to their inherent properties, such as fluorescence efficiency problems, etc., compared with current inorganic fluorescent substances, organic fluorescent substances still have a wide range of applications. Such as applied to flow cytometry, applied to antibody labeling and so on.
生物功能化材料一直是材料研究学领域的热门领域,在生物功能化材料中,纳米材料自从上个世纪80年代以来由于其特殊的物理化学性质,越来越受到科学家们的重视,因而利用纳米技术研究和解决生物领域的重大问题也成为重要的前沿研究领域之一。Biofunctional materials have always been a hot field in the field of materials research. In biofunctional materials, nanomaterials have attracted more and more attention from scientists due to their special physical and chemical properties since the 1980s. Technology research and solving major problems in the field of biology have also become one of the important frontier research fields.
然而将有机荧光材料和纳米材料结合起来作为功能化材料应用于生物领域却没有较多的深入研究,国外已有研究将此类型的荧光材料通过化学的方法修饰在纳米材料的表面。然而将荧光物质包裹于纳米材料之内却没有相关的报道,更没有将纳米粒子的表面活化,或称“表面生物功能化”,即使表面可以连接核酸、蛋白质、核苷酸、氨基酸、抗体、多肽、动植物细胞、亚细胞结构、病毒、细菌等等生物大分子或者生物体本身的能力的研究。However, the combination of organic fluorescent materials and nanomaterials as functional materials in the biological field has not been studied in depth. There have been studies abroad that this type of fluorescent materials have been chemically modified on the surface of nanomaterials. However, there is no relevant report on encapsulating fluorescent substances in nanomaterials, and there is no activation of the surface of nanoparticles, or "surface biofunctionalization", even though the surface can be connected to nucleic acids, proteins, nucleotides, amino acids, antibodies, Peptides, animal and plant cells, subcellular structures, viruses, bacteria and other biological macromolecules or the ability of the organism itself.
发明内容Contents of the invention
所要解决的技术问题technical problem to be solved
本发明需要解决的技术问题是提供一种表面生物功能化的核壳型荧光纳米粒子及其制备方法和应用,以克服现有技术中荧光物质仅修饰于纳米材料表面,以及无法使荧光纳米材料同时具备生物分子结合功能的缺陷。The technical problem to be solved in the present invention is to provide a core-shell type fluorescent nanoparticle with surface biofunctionalization and its preparation method and application, so as to overcome the fluorescent substance in the prior art that is only modified on the surface of nanomaterials and cannot make fluorescent nanomaterials At the same time, it has the defect of biomolecular binding function.
技术方案Technical solutions
本发明的内容之一是提供一种表面生物功能化的核壳型荧光纳米粒子,具备内核和外壳的核壳型结构:其内核层中含荧光物质;外壳层由荧光通透物质构成;外壳层表面为有机官能团的修饰层。One of the contents of the present invention is to provide a core-shell fluorescent nanoparticle with surface biofunctionalization, which has a core-shell structure with a core and an outer shell: the inner core layer contains fluorescent substances; the outer shell layer is composed of fluorescent transparent substances; the outer shell The surface of the layer is a modified layer of organic functional groups.
上述的生物功能化荧光纳米粒子的一种优选方案为,所说的有机官能团为氨基、羧基或者巯基,或者其组合。A preferred solution of the above biologically functionalized fluorescent nanoparticles is that the organic functional group is an amino group, a carboxyl group or a mercapto group, or a combination thereof.
上述的生物功能化荧光纳米粒子的另一种优选方案为,所说的荧光物质为异硫氰酸荧光素、四乙基罗丹明、四甲基异硫氰酸罗丹明、藻红蛋白,或者其组合,较佳地选择异硫氰酸荧光素FITC。Another preferred version of the above-mentioned biofunctionalized fluorescent nanoparticles is that the fluorescent substance is fluorescein isothiocyanate, tetraethylrhodamine, tetramethylrhodamine isothiocyanate, phycoerythrin, or Its combination is preferably fluorescein isothiocyanate FITC.
上述的生物功能化荧光纳米粒子的另一种优选方案为,所说的外壳层成分为二氧化硅、琼脂糖、烯烃聚合物、聚丙烯腈或环氧化合物,或者其组合。Another preferred solution of the above-mentioned biologically functionalized fluorescent nanoparticles is that the shell layer component is silicon dioxide, agarose, olefin polymer, polyacrylonitrile or epoxy compound, or a combination thereof.
本领域的普通技术人员无需特别的实验即可理解,制备所说的外壳层成分可以是无机包裹层,例如氨基硅烷、巯基硅烷,还可以是有机包裹层,例如糖苷、蛋白质等。无机包裹层优选氨基硅烷,有机包裹层优选糖苷。较佳地,其成分选自二氧化硅、琼脂糖、烯烃聚合物、聚丙烯腈、环氧化合物、或其组合;最佳地,所述内核层的外壳成分是二氧化硅。Those skilled in the art can understand without special experiments that the components for preparing the shell layer can be inorganic coatings such as aminosilane and mercaptosilane, or organic coatings such as glycosides and proteins. The inorganic coating layer is preferably aminosilane, and the organic coating layer is preferably glycoside. Preferably, its composition is selected from silica, agarose, olefin polymer, polyacrylonitrile, epoxy compound, or a combination thereof; most preferably, the shell composition of the inner core layer is silica.
本发明的内容之二是提供一种制备所说的表面生物功能化的核壳型荧光纳米粒子的方法,包括如下步骤:The second content of the present invention is to provide a method for preparing said surface biofunctionalized core-shell fluorescent nanoparticles, comprising the following steps:
(1)提供异丙醇和荧光物质的水溶液;(1) provide the aqueous solution of isopropanol and fluorescent substance;
(2)将氨水和正硅酸乙酯分别先后加入步骤(1)所说的水溶液中,在室温的条件下反应3~5个小时得到荧光粒子;(2) adding ammonia water and tetraethyl orthosilicate to the aqueous solution of step (1) successively, and reacting at room temperature for 3 to 5 hours to obtain fluorescent particles;
(3)在步骤(2)的荧光粒子的醇溶液中加入氨基化、羧基化或者巯基化试剂,在25~60℃下反应1~6小时,即获得表面生物功能化的荧光纳米粒子。(3) Add an amination, carboxylation or mercaptolation reagent to the alcohol solution of fluorescent particles in step (2), and react at 25-60° C. for 1-6 hours to obtain surface biofunctionalized fluorescent nanoparticles.
本发明同时提供上述的表面生物功能化的核壳型荧光纳米粒子的另一种制备方法,包括如下步骤:The present invention also provides another method for preparing the above-mentioned surface biofunctionalized core-shell fluorescent nanoparticles, which includes the following steps:
(1)提供TritonX-100、正己醇、环己烷和荧光物质的微乳液;(1) Provide microemulsions of TritonX-100, n-hexanol, cyclohexane and fluorescent substances;
(2)将氨水和正硅酸乙酯分别先后加入步骤(1)所说的水溶液中,在室温的条件下反应8~15个小时得到荧光粒子;(2) adding ammonia water and tetraethyl orthosilicate to the aqueous solution of step (1) successively, and reacting at room temperature for 8 to 15 hours to obtain fluorescent particles;
(3)在步骤(2)的荧光粒子的醇溶液中加入氨基化、羧基化或者巯基化试剂,在25~60℃下反应1~6小时,即获得表面生物功能化的荧光纳米粒子。(3) Add an amination, carboxylation or mercaptolation reagent to the alcohol solution of fluorescent particles in step (2), and react at 25-60° C. for 1-6 hours to obtain surface biofunctionalized fluorescent nanoparticles.
上述的两种表面生物功能化的核壳型荧光纳米粒子的制备方法的优选方案为,所说的氨基化、羧基化或者巯基化试剂分别为N-(2-氨基乙基)-3-氨基丙基三甲氧基硅烷、3-巯基丙基三甲氧基硅烷、3-巯基丙基三甲氧基硅烷,也可以是巯基乙酸或者巯基丙酸。The preferred version of the preparation method of the above-mentioned two kinds of surface biofunctionalized core-shell fluorescent nanoparticles is that the amination, carboxylation or mercaptolation reagents are N-(2-aminoethyl)-3-amino Propyltrimethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-mercaptopropyltrimethoxysilane, or mercaptoacetic acid or mercaptopropionic acid.
本领域的普通技术人员无需特别的实验即可理解,所说的修饰剂为硅烷类修饰剂,但并不限于上述的几种。对于选定的外壳成分,一般技术人员可根据现有技术选用合适的外壳层形成剂。例如当外壳成分为二氧化硅时,可选用正硅酸乙酯或其它合适的外壳层形成剂。Those skilled in the art can understand without any special experiments that the modifier is a silane modifier, but is not limited to the above-mentioned ones. For the selected shell composition, a person of ordinary skill can select a suitable shell forming agent according to the prior art. For example, when the shell component is silica, tetraethyl orthosilicate or other suitable shell formers may be used.
上述的生物功能化荧光纳米粒子制备方法的一种优选方案为,所说的微乳液体系中含有TritonX-100、正己醇、环己烷按,其体积比为1∶1~3∶4~6。A preferred version of the above method for preparing biofunctional fluorescent nanoparticles is that the microemulsion system contains TritonX-100, n-hexanol, and cyclohexane, and its volume ratio is 1:1~3:4~6 .
本发明的内容之二是提供上述的生物功能化荧光纳米粒子的应用,所说的有机化官能团通过化学键与核酸、蛋白质、核苷酸、氨基酸或者其衍生物结合。The second content of the present invention is to provide the application of the above-mentioned biofunctionalized fluorescent nanoparticles, wherein the organic functional groups are combined with nucleic acids, proteins, nucleotides, amino acids or their derivatives through chemical bonds.
上述的生物功能化荧光纳米粒子的另一种应用为,所说的有机化官能团与动植物细胞或者亚细胞结构或者病毒颗粒结合。Another application of the above-mentioned biofunctional fluorescent nanoparticles is that the organic functional groups are combined with animal and plant cells or subcellular structures or virus particles.
有益效果Beneficial effect
1、本发明的生物功能化荧光纳米粒子与现有技术中荧光物质仅修饰于纳米材料表面相比,可以使纳米材料不但具备荧光标记能够方便地指示的性能之外,还具备有机官能团,通过化学键与核酸、蛋白质、核苷酸、氨基酸或者其衍生物结合,乃至与动植物细胞或者亚细胞结构或者病毒颗粒结合的生物应用功能。1. Compared with the fluorescent substances in the prior art that are only modified on the surface of nanomaterials, the biologically functionalized fluorescent nanoparticles of the present invention can make nanomaterials not only have the properties that can be easily indicated by fluorescent labels, but also have organic functional groups. The biological application function of combining chemical bonds with nucleic acids, proteins, nucleotides, amino acids or their derivatives, and even with animal and plant cells or subcellular structures or virus particles.
2、本发明的实验表明,将荧光物质包裹于纳米颗粒后,其发光性质稳定、颗粒分布均匀、表面光滑,是一种新型的超微检测纳米材料。2. The experiments of the present invention show that after the fluorescent substance is wrapped in nanoparticles, its luminescent property is stable, the particles are evenly distributed, and the surface is smooth. It is a new type of nanometer material for ultramicro detection.
3、本发明的生物功能化荧光纳米粒子其外壳层采用二氧化硅、琼脂糖等无毒、具有生物相容性的材料,使应用于生物化学领域成为可能。3. The shell layer of the biologically functionalized fluorescent nanoparticles of the present invention is made of non-toxic and biocompatible materials such as silicon dioxide and agarose, which makes it possible to be applied in the field of biochemistry.
4、本发明的制备方法采用成本低廉的有机荧光物质、外壳形成剂等,使得实际大规模生产具有可行性。4. The preparation method of the present invention adopts low-cost organic fluorescent substances, shell-forming agents, etc., so that the actual large-scale production is feasible.
5、采用纳米颗粒包裹荧光物质和生物功能基团,可以有效的发挥纳米材料的表面积优势,提高生物反应的效率、加快反应时间,同时减小反应体系的总量,使得进行微量检测和微量反应简便易行。5. The use of nanoparticles to wrap fluorescent substances and biological functional groups can effectively take advantage of the surface area of nanomaterials, improve the efficiency of biological reactions, speed up the reaction time, and reduce the total amount of the reaction system, enabling trace detection and trace reactions Simple and easy.
6、生物功能化的纳米粒子对于纳米水平上的生物材料的理化性质的研究提供了基础,同时进一步提供了扩大应用的可能性。6. Biologically functionalized nanoparticles provide a basis for the study of the physical and chemical properties of biological materials at the nanometer level, and further provide the possibility of expanding applications.
7、在本发明的纳米粒子上连接核酸、蛋白质、核苷酸、氨基酸、抗体、多肽、动植物细胞、亚细胞结构、病毒、细菌等等,可以广泛应用于各类分子的检测和疾病的示踪治疗。7. Linking nucleic acids, proteins, nucleotides, amino acids, antibodies, polypeptides, animal and plant cells, subcellular structures, viruses, bacteria, etc. to the nanoparticles of the present invention can be widely used in the detection of various molecules and the detection of diseases Tracer therapy.
附图说明Description of drawings
图1是二氧化硅包裹荧光纳米粒子的透射电子显微镜照片。从图中可以看出,包裹了荧光物质的纳米粒子具有很规则的形态,具有很好的单分散性,表明二氧化硅已经很好的将荧光物质包裹于其中。Figure 1 is a transmission electron micrograph of silica-coated fluorescent nanoparticles. It can be seen from the figure that the nanoparticles wrapped with the fluorescent substance have a very regular shape and good monodispersity, indicating that the silica has well wrapped the fluorescent substance in it.
图2是二氧化硅包裹荧光物质的纳米粒子的荧光显微镜照片。图中可以看出,包裹荧光物质纳米粒子具有很好的荧光性质,同时也进一步证明二氧化硅已经成功地将荧光物质包裹于其中。Fig. 2 is a fluorescent micrograph of nanoparticles coated with fluorescent substances by silica. It can be seen from the figure that the encapsulated fluorescent substance nanoparticles have good fluorescent properties, and it further proves that the silica has successfully encapsulated the fluorescent substance in it.
图3是二氧化硅包裹荧光物质的纳米粒子的荧光光谱。从图谱中可以看出,包裹荧光物质纳米粒子具有较好的荧光强度,同时也进一步证明二氧化硅已经成功地将荧光物质包裹于其中。Fig. 3 is the fluorescence spectrum of nanoparticles coated with fluorescent substances by silica. It can be seen from the spectrum that the nano-particles encapsulated with fluorescent substances have better fluorescence intensity, which further proves that the silica has successfully encapsulated the fluorescent substances in it.
图4是修饰巯基的纳米粒子的拉曼光谱。从图谱中可以看出,2167cm-1处是SH的拉曼光谱。1328cm-1归属为CH2的面外摇摆振动谱,1388cm-1和1464cm-1是CH2的伸缩振动峰位,而1594cm-1可指认为C-C链的伸缩振动峰位,2934cm-1附近的谱带则归属于CH2的反对称的伸缩振动,395cm-1处的峰是C-C链变形振动所产生的。(CH2)n和Si-O-的局域模的对称伸缩振动出现在1075cm-1附近。在1003cm-1和502cm-1处有相应的-O-Si-O-局域模的对称伸缩振动。1231cm-1处的峰位是C-Si的伸缩震动,668cm-1和730cm-1两处的拉曼峰位则是因为C-S键伸缩振动而产生。碳硅键、硅氧键、碳碳键、碳氢键以及碳硫键的拉曼峰的出现,表明了巯基化合物已被成功地连接到纳米粒子的表面上,并且有部分有效的巯基暴露在纳米粒子的表面上。Figure 4 is the Raman spectrum of nanoparticles modified with thiol groups. It can be seen from the spectrum that the Raman spectrum of SH is at 2167cm -1 . 1328cm -1 is assigned to the out-of-plane rocking vibration spectrum of CH 2 , 1388cm -1 and 1464cm -1 are the stretching vibration peaks of CH 2 , and 1594cm -1 can be assigned to the stretching vibration peak of CC chain, and the peak around 2934cm -1 The bands belong to the antisymmetric stretching vibration of CH 2 , and the peak at 395cm -1 is produced by the CC chain deformation vibration. The symmetrical stretching vibrations of localized modes of (CH 2 )n and Si-O - appear around 1075cm -1 . There are corresponding symmetrical stretching vibrations of -O -Si-O - localized modes at 1003cm -1 and 502cm -1 . The peak at 1231cm -1 is the stretching vibration of C-Si, and the Raman peaks at 668cm -1 and 730cm -1 are caused by the stretching vibration of CS bond. The appearance of Raman peaks of carbon-silicon bonds, silicon-oxygen bonds, carbon-carbon bonds, carbon-hydrogen bonds, and carbon-sulfur bonds indicates that mercapto compounds have been successfully attached to the surface of nanoparticles, and some effective mercapto groups are exposed on the surface of nanoparticles. on the surface of nanoparticles.
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.
下列实施例中未注明具体条件的实验方法,通常按照常规条件,如:化工产品手册,或按照制造厂商所建议的条件。所有无机化学试剂和有机溶剂购自上海化学试剂厂,异硫氰酸荧光素、N-(2-氨基乙基)-3-氨基丙基三甲氧基硅烷、巯基乙酸、3-巯基丙基三甲氧基硅烷(MPTS)购自Sigma公司。For the experimental methods that do not specify specific conditions in the following examples, generally follow conventional conditions, such as: chemical product manuals, or according to the conditions suggested by the manufacturer. All inorganic chemical reagents and organic solvents were purchased from Shanghai Chemical Reagent Factory, fluorescein isothiocyanate, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, mercaptoacetic acid, 3-mercaptopropyltrimethyl Oxygensilane (MPTS) was purchased from Sigma.
实施例1Example 1
核壳型荧光纳米粒子的制备方法一
将异丙醇和水按照5∶1的比例均匀混合,超声5min。称取0.1~0.8mg的荧光物质异硫氰酸荧光素FITC,配置成水溶液,超声处理10min。取上层清夜倒入三颈烧瓶中,不断搅拌使其保持分散状态。取1mL的浓氨水,将其缓慢加入到不断搅拌的溶液体系中。接着取1~3mL的正硅酸乙酯,同样将其缓慢加入到不断搅拌的溶液体系中。体系在室温的条件下反应3~5个小时。将反应产物倒出,用二次蒸馏水洗涤粒子3~5次。清洗后的粒子在20~50℃的温度下真空干燥5小时,收集粒子备用。从图1中我们可以看出二氧化硅已经很好地将荧光物质包裹在其中。Mix isopropanol and water uniformly at a ratio of 5:1, and sonicate for 5 minutes. Weigh 0.1-0.8 mg of fluorescent substance fluorescein isothiocyanate FITC, configure it into an aqueous solution, and process it ultrasonically for 10 min. Pour the upper clear layer into a three-necked flask, and keep stirring to keep it in a dispersed state. Take 1mL of concentrated ammonia water and slowly add it into the constantly stirring solution system. Then take 1-3 mL of tetraethyl orthosilicate, and also slowly add it into the constantly stirring solution system. The system was reacted at room temperature for 3 to 5 hours. The reaction product was poured out, and the particles were washed 3 to 5 times with twice distilled water. The cleaned particles were vacuum-dried for 5 hours at a temperature of 20-50° C., and the particles were collected for future use. From Figure 1, we can see that the silicon dioxide has well wrapped the fluorescent substance in it.
实施例2Example 2
核壳型荧光纳米粒子的制备方法二Preparation Method 2 of Core-shell Fluorescent Nanoparticles
将TritonX-100、正己醇、环己烷按1∶2∶5的比例均匀混合,形成透明稳定的微乳液体系。将上述微乳液体系置于超声波中处理30~60分钟,向其中加入荧光物质异硫氰酸荧光素FITC 0.5mg,用超声波处理6分钟后取出上层液倒入三颈烧瓶中,搅拌30分钟使之均匀。取1mL浓氨水用2mL二次蒸馏水稀释,30分钟后将其缓慢加入到不断搅拌的微乳液中,持续搅拌30分钟使氨水均匀分散在微乳液中。1小时后,向微乳液中滴加1~3mL的正硅酸乙酯,同时不断地搅拌10小时,并将体系的温度保持在15~30℃之间。向体系中加入丙酮使粒子沉淀,或者将体系静置过夜使粒子自然沉淀,使用乙醇清洗粒子。在真空的条件下干燥粒子样品。Mix TritonX-100, n-hexanol and cyclohexane uniformly at a ratio of 1:2:5 to form a transparent and stable microemulsion system. Put the above microemulsion system in ultrasonic treatment for 30-60 minutes, add fluorescent substance fluorescein isothiocyanate FITC 0.5mg to it, use ultrasonic treatment for 6 minutes, take out the supernatant liquid and pour it into a three-necked flask, stir for 30 minutes It's even. Take 1mL of concentrated ammonia water and dilute it with 2mL double-distilled water, slowly add it into the microemulsion under constant stirring after 30 minutes, and keep stirring for 30 minutes to disperse the ammonia water evenly in the microemulsion. After 1 hour, 1-3 mL of tetraethyl orthosilicate was added dropwise to the microemulsion, while stirring continuously for 10 hours, and the temperature of the system was kept between 15-30°C. Add acetone to the system to precipitate the particles, or let the system stand overnight to allow the particles to settle naturally, and use ethanol to wash the particles. Dry the particle sample under vacuum.
实施例3Example 3
荧光纳米粒子表面的氨基修饰Amino modification on the surface of fluorescent nanoparticles
取20mg实施例1或2中制得的荧光纳米粒子,加入30~50mL的甲醇和丙三醇按5∶3比例组成的混合液中,用超声波处理20~60分钟;称取1~3mL AEAPS[N-(2-氨基乙基)-3-氨基丙基三甲氧基硅烷],用超声波处理10~60分钟;将这两种溶液混合均匀,在60℃的条件下反应5小时,然后取出粒子并用甲醇清洗3次,接着在40~80℃真空干燥2小时,收集粒子得到表面修饰有氨基的生物功能化的荧光纳米粒子。Take 20 mg of the fluorescent nanoparticles prepared in Example 1 or 2, add 30-50 mL of methanol and glycerol in a 5:3 mixture, and use ultrasonic treatment for 20-60 minutes; weigh 1-3 mL of AEAPS [N-(2-aminoethyl)-3-aminopropyltrimethoxysilane], ultrasonic treatment for 10 to 60 minutes; mix the two solutions evenly, react at 60°C for 5 hours, and then take out The particles were washed with methanol for 3 times, followed by vacuum drying at 40-80° C. for 2 hours, and the particles were collected to obtain biofunctionalized fluorescent nanoparticles with amino groups modified on the surface.
实施例4Example 4
荧光纳米粒子表面的羧基修饰Carboxyl modification on the surface of fluorescent nanoparticles
取实施例1或2中制得的荧光纳米粒子加入到组成为乙酸乙醇的缓冲溶液中(pH=4.5),超声混合均匀;3-巯基丙基三甲氧基硅烷(MPTS)加入到同样的缓冲溶液中。将两种缓冲溶液混合,在常规的温度条件下反应2~4个小时,离心分离粒子,用同样的缓冲溶液洗涤三次后,在60℃下真空干燥,收集粒子。Take the fluorescent nanoparticles prepared in Example 1 or 2 and add them into a buffer solution composed of ethanol acetate (pH=4.5), and mix them uniformly by ultrasonic; add 3-mercaptopropyltrimethoxysilane (MPTS) into the same buffer solution in solution. The two buffer solutions are mixed, reacted under normal temperature conditions for 2-4 hours, centrifuged to separate the particles, washed three times with the same buffer solution, dried in vacuum at 60° C., and collected the particles.
将收集的粒子分散于同样的缓冲溶液中,向溶液体系中加入巯基乙酸,将溶液分散均匀,体系在常温下反应2~4个小时后,离心分离收集粒子,洗涤数遍后真空干燥,得到表面修饰羧基的生物功能化的荧光纳米粒子。Disperse the collected particles in the same buffer solution, add thioglycolic acid to the solution system, disperse the solution evenly, react the system at room temperature for 2 to 4 hours, centrifuge to collect the particles, wash several times and then vacuum dry to obtain Biofunctionalized fluorescent nanoparticles with surface-modified carboxyl groups.
实施例5Example 5
荧光纳米粒子表面的巯基修饰Thiol group modification on the surface of fluorescent nanoparticles
取实施例1或2中制得的荧光纳米粒子加入到乙酸乙醇缓冲液中(pH=4.5),超声混和均匀;同时,将3-巯基丙基三甲氧基硅烷(MPTS)加入到另一乙酸乙醇缓冲液中。混合上述两种溶液,在25℃的情况下反应1h后,取出粒子,用乙酸乙醇的缓冲液(pH=4.5)清洗三次后,在60℃时真空干燥2h,收集表粒子得到表明修饰有巯基的生物功能化荧光纳米粒子。从图4的拉曼表征图谱中可以看出,巯基已经被修饰到荧光纳米粒子的表面。Take the fluorescent nanoparticles prepared in Example 1 or 2 and add them to ethanol acetate buffer (pH=4.5), and mix them uniformly by ultrasonic; at the same time, add 3-mercaptopropyltrimethoxysilane (MPTS) to another acetic acid in ethanol buffer. Mix the above two solutions, react at 25°C for 1 hour, take out the particles, wash with ethanol acetate buffer solution (pH=4.5) three times, and dry them in vacuum at 60°C for 2 hours, collect the surface particles to obtain sulfhydryl groups biofunctionalized fluorescent nanoparticles. It can be seen from the Raman characterization spectrum in Figure 4 that the sulfhydryl groups have been modified to the surface of the fluorescent nanoparticles.
实施例6Example 6
氨基修饰的荧光纳米粒子应用于蛋白分离Amino-modified fluorescent nanoparticles for protein separation
取1~3mg如实施例3制备的表面修饰氨基的生物功能化荧光纳米粒子,加入到pH为7.0~8.0的磷酸盐缓冲体系中,加入用量为50~200μL交联剂如戊二醛等等,形成混合溶液。所述的混合溶液用超声波处理10~30分钟。在适当的温度条件下,反应4~6小时。离心分离去除上清后,然后用磷酸盐缓冲液超声洗涤2~3次后,重新将粒子分散于磷酸缓冲溶液。Take 1-3 mg of biofunctional fluorescent nanoparticles with surface-modified amino groups prepared as in Example 3, and add them to a phosphate buffer system with a pH of 7.0-8.0, and add a cross-linking agent such as glutaraldehyde in an amount of 50-200 μL , forming a mixed solution. The mixed solution is treated with ultrasonic wave for 10-30 minutes. Under appropriate temperature conditions, react for 4 to 6 hours. After centrifuging to remove the supernatant, and then ultrasonically washing with phosphate buffer saline for 2-3 times, the particles were re-dispersed in the phosphate buffer solution.
称取一定量的中药(灵芝、当归、黄芪等等),按照传统中药的煎药方法进行处理,离心分离去除溶液中的杂质,收集含蛋白成分的上清备用。Weigh a certain amount of traditional Chinese medicine (ganoderma lucidum, angelica, astragalus, etc.), process according to the decoction method of traditional Chinese medicine, centrifuge to remove impurities in the solution, and collect the supernatant containing protein components for later use.
取一定量的上清溶液,向其中加入一定量的粒子溶液,振荡混匀,在室温下反应1~3小时,离心分离去除上清液,用磷酸缓冲溶液洗涤1~2次,最后将所得的连有蛋白的粒子重新分散于磷酸缓冲溶液中备用。Take a certain amount of supernatant solution, add a certain amount of particle solution to it, shake and mix, react at room temperature for 1 to 3 hours, centrifuge to remove the supernatant, wash with phosphate buffer solution for 1 to 2 times, and finally wash the obtained The protein-linked particles were redispersed in phosphate buffer solution for later use.
将上述连有蛋白的粒子溶液,加入到体外培养的癌细胞或者正常细胞中,观察各种不同中药中不同蛋白成分对于癌细胞的凋亡和正常细胞的增殖能力的作用。Add the above-mentioned protein-linked particle solution to cancer cells or normal cells cultured in vitro, and observe the effect of different protein components in various traditional Chinese medicines on the apoptosis of cancer cells and the proliferation ability of normal cells.
实施例7Example 7
羧基修饰的荧光纳米粒子应用于RNA干扰Carboxyl-modified fluorescent nanoparticles for RNA interference
取一定量上述实施例4中制备的已修饰好羧基的生物功能化荧光纳米粒子,加入到pH为7.0~8.0的磷酸盐缓冲体系中,形成混合溶液。所述的混合溶液用超声波处理10~30分钟。A certain amount of the carboxyl-modified biofunctionalized fluorescent nanoparticles prepared in the above-mentioned Example 4 was added to a phosphate buffer system with a pH of 7.0-8.0 to form a mixed solution. The mixed solution is treated with ultrasonic wave for 10-30 minutes.
取足够量的修饰有氨基的特定序列的双链干扰的小RNA(siRNA),加入到含约2mL的上述粒子的混合溶液中。在室温下反应3小时,并保持不断振动,从而将siRNA上的氨基与外壳层上的羧基在固定剂的作用下进行反应,并直接连接于外壳层。反应结束后,超滤分离出所述的粒子,用磷酸盐缓冲液洗涤3次。这样得到的连接有双链干扰的小RNA的荧光纳米粒子置于磷酸盐缓冲液中保存。Take a sufficient amount of double-stranded interfering small RNA (siRNA) modified with amino groups in a specific sequence, and add it to the mixed solution containing about 2 mL of the above-mentioned particles. React at room temperature for 3 hours, and keep vibrating continuously, so that the amino group on the siRNA and the carboxyl group on the outer shell react under the action of a fixative, and are directly connected to the outer shell. After the reaction, the particles were separated by ultrafiltration and washed three times with phosphate buffer. The thus obtained fluorescent nanoparticles linked with double-stranded interfering small RNA are stored in phosphate buffer.
将上述连有siRNA的粒子溶液,加入到体外培养的具有吞噬作用的细胞中,观察不同siRNA序列对于细胞特异基因抑制作用,也可以用于细胞的转染示踪和实时监测。The above-mentioned particle solution linked with siRNA is added to cells with phagocytosis cultured in vitro to observe the inhibitory effect of different siRNA sequences on cell-specific genes, and can also be used for cell transfection tracking and real-time monitoring.
实施例8Example 8
修饰氨基的荧光纳米粒子应用于细胞监测Fluorescent nanoparticles modified with amino groups for cell monitoring
取1~3mg如实施例3制备的表面修饰氨基的生物功能化荧光纳米粒子,加入到pH为7.0~8.0的磷酸盐缓冲体系中,加入用量为50~200μL交联剂,形成混合溶液。所述的混合溶液用超声波处理10~30分钟。在适当的温度条件下,反应4~6小时。离心分离去除上清后,然后用磷酸盐缓冲液超声洗涤2~3次后,重新将粒子分散于磷酸缓冲溶液。Take 1-3 mg of biofunctional fluorescent nanoparticles with surface-modified amino groups prepared as in Example 3, and add them into a phosphate buffer system with a pH of 7.0-8.0, and add 50-200 μL of cross-linking agent to form a mixed solution. The mixed solution is treated with ultrasonic wave for 10-30 minutes. Under appropriate temperature conditions, react for 4 to 6 hours. After centrifuging to remove the supernatant, and then ultrasonically washing with phosphate buffer saline for 2-3 times, the particles were re-dispersed in the phosphate buffer solution.
取约3微克的单克隆抗体,加入到含约2mL的上述粒子的混合溶液中。在2~10℃的反应温度下反应3小时,从而将抗体上的氨基与外壳层上的氨基在固定剂的作用下进行反应,使抗体通过Schiff Bond(席夫键)直接连接于外壳层。反应结束后,离心分离出所述的粒子,用磷酸盐缓冲液洗涤3次。这样得到的修饰有单克隆抗体的荧光纳米粒子置于磷酸盐缓冲液中保存,利用含有抗体分子的荧光纳米颗粒,可以快速、精确地检测极微量有害细菌。这种纳米粒子加入检测样本的溶解液里,就会与细菌粘着在一块;然后通过离心方法,根据纳米粒子与细菌细胞之问的大小的不同,可以使细菌与纳米颗粒一起沉淀下来;分离下来的细菌上附着有从纳米颗粒,根据这些粒子的发光现象就可以确定所要检测的细菌是否存在。该检测法使用抗目标细菌的特异性抗体制作荧光粒子,使检测的特异性很高;另外,由于同时有数千个荧光粒子附着细菌,所以即使单个细胞也可以检测到。About 3 μg of monoclonal antibody was added to the mixed solution containing about 2 mL of the above-mentioned particles. React at a reaction temperature of 2-10°C for 3 hours, so that the amino groups on the antibody and the amino groups on the shell layer react under the action of a fixative, so that the antibody is directly connected to the shell layer through Schiff Bond. After the reaction, the particles were separated by centrifugation and washed three times with phosphate buffer. The thus obtained fluorescent nanoparticles modified with monoclonal antibodies are stored in phosphate buffer, and the fluorescent nanoparticles containing antibody molecules can be used to quickly and accurately detect extremely small amounts of harmful bacteria. When this nanoparticle is added to the solution of the test sample, it will stick to the bacteria; then, by centrifugation, according to the size difference between the nanoparticle and the bacterial cell, the bacteria and the nanoparticle can be precipitated together; separated Nanoparticles are attached to the bacteria, and the existence of the bacteria to be detected can be determined according to the luminescent phenomenon of these particles. This detection method uses specific antibodies against target bacteria to make fluorescent particles, which makes the detection specificity very high; in addition, since thousands of fluorescent particles are attached to bacteria at the same time, even a single cell can be detected.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610025985 CN1896738A (en) | 2006-04-24 | 2006-04-24 | Fluorescent nano-particle with surface biological function, its production and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610025985 CN1896738A (en) | 2006-04-24 | 2006-04-24 | Fluorescent nano-particle with surface biological function, its production and use |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1896738A true CN1896738A (en) | 2007-01-17 |
Family
ID=37609298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200610025985 Pending CN1896738A (en) | 2006-04-24 | 2006-04-24 | Fluorescent nano-particle with surface biological function, its production and use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1896738A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101526534A (en) * | 2009-03-10 | 2009-09-09 | 沈鹤柏 | Fluorescence immune chromatography test paper and preparing method and application thereof |
CN101440279B (en) * | 2008-12-17 | 2011-11-16 | 暨南大学 | Fluorescent nano-particle with composite silica shell structure and preparation thereof |
CN101712929B (en) * | 2008-10-08 | 2011-12-28 | 青岛生物能源与过程研究所 | Method for carrying out microalgae photobiological culture by utilizing luminous particle |
CN103105492A (en) * | 2013-01-17 | 2013-05-15 | 重庆市科学技术研究院 | Fluorescence immunochromatography flu virus detection test paper |
CN104897889A (en) * | 2015-05-28 | 2015-09-09 | 山东省医学科学院基础医学研究所 | Preparation method of fluorescent SiO2 colloidal reagent, and test paper adopting fluorescent SiO2 colloidal reagent |
CN106118636A (en) * | 2016-06-27 | 2016-11-16 | 高大元 | A kind of preparation method of fluorescence silicon oxide nano-particle |
CN106165129A (en) * | 2014-04-10 | 2016-11-23 | 欧司朗光电半导体有限公司 | Light emitting device and method for manufacturing the light emitting device |
CN109444251A (en) * | 2018-11-23 | 2019-03-08 | 亿纳谱(浙江)生物科技有限公司 | Application of the nanomatrix in detection of nucleic acids |
-
2006
- 2006-04-24 CN CN 200610025985 patent/CN1896738A/en active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101712929B (en) * | 2008-10-08 | 2011-12-28 | 青岛生物能源与过程研究所 | Method for carrying out microalgae photobiological culture by utilizing luminous particle |
CN101440279B (en) * | 2008-12-17 | 2011-11-16 | 暨南大学 | Fluorescent nano-particle with composite silica shell structure and preparation thereof |
CN101526534A (en) * | 2009-03-10 | 2009-09-09 | 沈鹤柏 | Fluorescence immune chromatography test paper and preparing method and application thereof |
CN103105492A (en) * | 2013-01-17 | 2013-05-15 | 重庆市科学技术研究院 | Fluorescence immunochromatography flu virus detection test paper |
CN106165129A (en) * | 2014-04-10 | 2016-11-23 | 欧司朗光电半导体有限公司 | Light emitting device and method for manufacturing the light emitting device |
US10388836B2 (en) | 2014-04-10 | 2019-08-20 | Osram Opto Semiconductors Gmbh | Light-emitting device and method for producing a light-emitting device |
CN104897889A (en) * | 2015-05-28 | 2015-09-09 | 山东省医学科学院基础医学研究所 | Preparation method of fluorescent SiO2 colloidal reagent, and test paper adopting fluorescent SiO2 colloidal reagent |
CN104897889B (en) * | 2015-05-28 | 2017-03-01 | 山东省医学科学院基础医学研究所 | Fluorescence SiO2The preparation method of colloidal agent and use fluorescence SiO2The reagent paper of colloidal agent |
CN106118636A (en) * | 2016-06-27 | 2016-11-16 | 高大元 | A kind of preparation method of fluorescence silicon oxide nano-particle |
CN109444251A (en) * | 2018-11-23 | 2019-03-08 | 亿纳谱(浙江)生物科技有限公司 | Application of the nanomatrix in detection of nucleic acids |
CN109444251B (en) * | 2018-11-23 | 2021-12-21 | 亿纳谱(浙江)生物科技有限公司 | Application of nano matrix in nucleic acid detection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1896738A (en) | Fluorescent nano-particle with surface biological function, its production and use | |
CN1284795C (en) | Magnetic nanoparticle nucleic acid separator, its preparation method and application | |
CN1215902C (en) | Magnetic fluorescent double functional microballoon with core-shell structure and preparation method thereof | |
CN102558463B (en) | One-pot synthesis of phenylboronic acid polymerized magnetic nanocomposites and its preparation method and application | |
CN102120168B (en) | Fluorescence-encoded magnetic microspheres with multifunctional core-shell structure and preparation method thereof | |
Mueller et al. | Inducible site-selective bottom-up assembly of virus-derived nanotube arrays on RNA-equipped wafers | |
CN103990423A (en) | Single-stranded DNA aptamer modified SiO2/Fe3O4 magnetic microsphere preparation method | |
CN102851021B (en) | High-brightness non-toxic fluorescent quantum dot nanometer composite probe and preparation method thereof | |
CN109705840A (en) | Preparation method of high-luminescence quantum dot fluorescent microspheres based on affinity assembly | |
CN111349351B (en) | A kind of preparation method of photonic crystal microspheres based on multi-shell nanoparticles | |
CN106179261A (en) | A kind of preparation method of golden nanometer particle surface fluorescence molecularly imprinted polymer | |
CN103275273A (en) | Preparation method of core-shell molecular imprinting nano-material, and application of nano-material | |
Zhang et al. | One-step and high-density protein immobilization on epoxysilane-modified silica nanoparticles | |
CN100469854C (en) | A kind of magnetic fluorescent nanometer microsphere and its preparation method and application | |
CN108918858B (en) | Preparation method of quantum dot-antibody immune complex | |
CN104928275B (en) | A kind of preparation method of bacterial spore functional microsphere and application | |
CN105802605A (en) | Preparation method of fluorogold nanocomposite used for cell imaging | |
CN101672847A (en) | Preparation method of protein chip glass carrier | |
CN114459877B (en) | DNA tetrahedron composite magnetic nano material for enriching exosomes and preparation thereof | |
CN101747518B (en) | A kind of composite polymer microsphere and preparation method thereof | |
CN108659249B (en) | Janus polymer particle and preparation method thereof | |
KR101368076B1 (en) | Surface-modified fluorescent silica nanoparticles with excellent aqeous dispersibility and preparing method thereof | |
CN106947105B (en) | Surface modification method to reduce the non-specific adsorption of proteins on the surface of micro-nanoparticles | |
CN107199336A (en) | One-step method prepares the silicon dioxide microsphere of Surface coating nano-Ag particles | |
CN107674669A (en) | A kind of macromolecule composite coding microballoon and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |